George R Thompson
George R Thompson
Verified email at
Cited by
Cited by
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ...
Clinical Infectious Diseases 63 (4), e1-e60, 2016
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlledá…
JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ...
The Lancet 387 (10020), 760-769, 2016
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Groupá…
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
FM Marty, L Ostrosky-Zeichner, OA Cornely, KM Mullane, JR Perfect, ...
The Lancet Infectious Diseases 16 (7), 828-837, 2016
Coccidioidomycosis: epidemiology
J Brown, K Benedict, BJ Park, GR Thompson III
Clinical epidemiology 5, 185, 2013
Oropharyngeal candidiasis in the era of antiretroviral therapy
GR Thompson III, PK Patel, WR Kirkpatrick, SD Westbrook, D Berg, ...
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, andá…, 2010
Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection
GR Thompson III, NP Wiederhold, AC Vallor, NC Villareal, JS Lewis, ...
Antimicrobial agents and chemotherapy 52 (10), 3783-3785, 2008
Overview of antifungal agents
GR Thompson, J Cadena, TF Patterson
Clinics in chest medicine 30 (2), 203-215, 2009
Synergistic reactivation of latent HIV expression by ingenol-3-angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation
G Jiang, EA Mendes, P Kaiser, DP Wong, Y Tang, I Cai, A Fenton, ...
PLoS pathogens 11 (7), e1005066, 2015
Isavuconazole treatment of cryptococcosis and dimorphic mycoses
GR Thompson, A Rendon, R Ribeiro dos Santos, F Queiroz-Telles, ...
Reviews of Infectious Diseases 63 (3), 356-362, 2016
Valley Fever: Finding New Places for an Old Disease: Coccidioides immitis Found in Washington State Soil Associated With Recent Human Infection
AP Litvintseva, N Marsden-Haug, S Hurst, H Hill, L Gade, EM Driebe, ...
Clinical Infectious Diseases 60 (1), e1-e3, 2015
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole
GR Thompson, NP Wiederhold
Mycopathologia 170 (5), 291-313, 2010
Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans
GR Thompson III, NP Wiederhold, AW Fothergill, AC Vallor, BL Wickes, ...
Antimicrobial Agents and Chemotherapy 53 (1), 309-311, 2009
Fungal disease of the nose and paranasal sinuses
GR Thompson III, TF Patterson
Journal of Allergy and Clinical Immunology 129 (2), 321-326, 2012
NW Stockamp, GR Thompson
Infectious Disease Clinics 30 (1), 229-246, 2016
Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal
DM Engelthaler, ND Hicks, JD Gillece, CC Roe, JM Schupp, EM Driebe, ...
MBio 5 (4), e01464-14, 2014
Pulmonary aspergillosis
GR Thompson, TF Patterson
Seminars in respiratory and critical care medicine 29 (02), 103-110, 2008
Update on the optimal use of voriconazole for invasive fungal infections
A Lat, GR Thompson III
Infection and drug resistance 4, 43, 2011
Pulmonary coccidioidomycosis
GR Thompson
Seminars in respiratory and critical care medicine 32 (06), 754-763, 2011
Detecting infections rapidly and easily for candidemia trial, part 2 (DIRECT2): a prospective, multicenter study of the T2Candida panel
CJ Clancy, PG Pappas, J Vazquez, MA Judson, DP Kontoyiannis, ...
Clinical Infectious Diseases 66 (11), 1678-1686, 2018
The system can't perform the operation now. Try again later.
Articles 1–20